Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $755.78 billion, total revenue of $168.76 billion and a weighted average PE ratio of 43.20.
Market Cap
755.78B
Revenue
168.76B
Profits
17.49B
PE Ratio
43.20
Profit Margin
10.37%
Dividend Yield
0.22%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 194.99B | 2.86% | 1,384,253 | 45.20B |
| 2 | DHR | Danaher Corporation | 138.71B | 2.73% | 2,657,340 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.06B | 0.53% | 623,243 | 4.45B |
| 4 | NTRA | Natera, Inc. | 40.37B | 2.72% | 1,135,018 | 2.50B |
| 5 | A | Agilent Technologies, Inc. | 37.73B | 3.50% | 2,372,994 | 7.23B |
| 6 | WAT | Waters Corporation | 37.03B | 2.44% | 534,355 | 3.77B |
| 7 | IQV | IQVIA Holdings Inc. | 34.88B | 2.54% | 1,105,615 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 29.32B | 3.17% | 1,725,054 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 26.03B | 3.13% | 110,226 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 23.03B | -0.08% | 621,208 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 22.77B | -0.04% | 373,292 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 21.76B | 5.06% | 3,849,398 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.29B | 0.66% | 410,574 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 12.93B | 1.99% | 525,213 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.60B | 3.29% | 1,609,064 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 11.25B | 4.30% | 652,896 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.68B | 10.50% | 12,745,775 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 5.89B | 6.11% | 852,534 | 354.54M |
| 19 | TWST | Twist Bioscience Corporation | 5.83B | 4.80% | 1,263,077 | 409.48M |
| 20 | SHC | Sotera Health Company | 5.24B | 5.27% | 3,595,189 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 5.19B | 0.53% | 591,056 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 4.73B | 5.67% | 690,657 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.49B | 8.13% | 3,005,961 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 3.25B | 8.06% | 730,403 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 2.06B | 5.75% | 623,688 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.92B | 3.44% | 1,517,262 | 745.97M |
| 27 | PSNL | Personalis, Inc. | 1.53B | 3.83% | 5,512,609 | 64.52M |
| 28 | CDNA | CareDx, Inc. | 1.50B | 5.66% | 699,766 | 412.82M |
| 29 | OPK | OPKO Health, Inc. | 1.05B | -1.42% | 2,854,342 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 744.90M | 3.89% | 262,621 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 593.01M | 1.31% | 249,620 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 576.13M | 3.92% | 881,682 | 829.00M |
| 33 | BDSX | Biodesix, Inc. | 229.38M | 9.93% | 85,959 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 156.61M | 1.25% | 244,120 | 1.95M |
| 35 | BNR | Burning Rock Biotech Limited | 123.39M | -0.43% | 25,338 | 74.58M |
| 36 | XGN | Exagen Inc. | 111.62M | 5.96% | 179,733 | 68.38M |
| 37 | PRPO | Precipio, Inc. | 47.33M | 1.38% | 152,013 | 25.83M |
| 38 | MDXH | MDxHealth SA | 25.16M | -1.03% | 289,013 | 110.97M |
| 39 | QUCY | Quantum Cyber N.V. | 20.97M | 5.93% | 1,320,297 | 537.08K |
| 40 | MBAI | Check-Cap Ltd. | 8.96M | 8.85% | 13,355 | - |
| 41 | ADVB | Advanced Biomed Inc. | 8.80M | 5.65% | 40,701 | - |
| 42 | XWEL | XWELL, Inc. | 8.41M | 7.10% | 90,404 | 28.83M |
| 43 | NDRA | ENDRA Life Sciences Inc. | 6.97M | 15.34% | 114,689 | - |
| 44 | ISPC | iSpecimen Inc. | 3.65M | 10.92% | 315,836 | 1.03M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 3.53M | -1.37% | 240,332 | 5.66M |